Duaklir Pressair and Ranibizumab ophthalmic
Determining the interaction of Duaklir Pressair and Ranibizumab ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aclidinium / formoterol
Brand name: Duaklir Pressair
Synonyms: n.a.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Duaklir Pressair-Ranitidine
- Duaklir Pressair-Ranitidine Capsule
- Duaklir Pressair-Ranitidine Hydrochloride
- Duaklir Pressair-Ranitidine Injection
- Duaklir Pressair-Ranitidine Suspension
- Duaklir Pressair-Ranitidine Syrup
- Ranibizumab ophthalmic-Dual Action Complete
- Ranibizumab ophthalmic-Duavee
- Ranibizumab ophthalmic-Duavee (combination)
- Ranibizumab ophthalmic-Duet DHA
- Ranibizumab ophthalmic-Duet DHA 400
- Ranibizumab ophthalmic-Duet DHA Balanced